Drug · DIN 02464713
PROCYSBI
ALSO KNOWN AS MERCAPTAMINE BITARTRATE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 17, 2025; first marketed October 17, 2017.
- Drug Identification Number (DIN)
- 02464713
- Company (DIN owner)
- Amgen Canada IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule (Delayed-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Mercaptamine A16AA04
- Class
- Human
- Record last updated
- September 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CYSTEAMINE (CYSTEAMINE BITARTRATE) | 75 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 17, 2025: NOC 35207New Drug Submission (NDS) · Administrative: Merger/Buy-out
- June 13, 2017: NOC 19408New Drug Submission (NDS)
Other DINs named PROCYSBI
- DIN 02464705 · Marketed